InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,629.40
(
0.25%
)
US TECH 100
19,846.40
(
0.27%
)
Dow Jones
40,179.01
(
0.45%
)
Brent Oil
84.21
(
-0.46%
)
Bitcoin
63,351.20
(
4.24%
)

Replies to post #1584 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #1584 on Enanta Pharmaceuticals Inc (ENTA)
icon url

DewDiligence

01/30/18 9:41 AM

#1585 RE: guyschmid #1584

Please see #msg-138077440.
icon url

DaveAu

01/30/18 9:42 AM

#1586 RE: guyschmid #1584

I think everyone was expecting Merck to take the biggest hit as they have a weak drug and Mavyret has both lower price and shorter treatment period. I don't see why it matters which of the competitors are losing share though.